Featured Posts
Blog
Free the Economy podcast: Drug costs and benefits with Sally Pipes
In this week’s episode we cover reforms to the Endangered Species Act, attacks on US tech firms, nuclear power innovation,…
National Review
Telehealth Is Less Promising Than It First Seemed
A key issue facing Congress in its postelection, “lame duck” session is whether to extend regulatory flexibilities expiring at year end that make telehealth services more…
City Journal
The FTC Jettisons Economics—and Law
The Federal Trade Commission is stepping up its pursuit of its new favorite bogeyman: Pharmacy Benefit Managers. Two months ago, the FTC issued an …
Search Posts
Blog
Free the Economy podcast: Drug costs and benefits with Sally Pipes
In this week’s episode we cover reforms to the Endangered Species Act, attacks on US tech firms, nuclear power innovation,…
National Review
Telehealth Is Less Promising Than It First Seemed
A key issue facing Congress in its postelection, “lame duck” session is whether to extend regulatory flexibilities expiring at year end that make telehealth services more…
City Journal
The FTC Jettisons Economics—and Law
The Federal Trade Commission is stepping up its pursuit of its new favorite bogeyman: Pharmacy Benefit Managers. Two months ago, the FTC issued an …
HeartLand Daily News
FDA Hid COVID Shot Side Effects—Congressional Report
Heartland Daily News cited CEI on COVID public health concerns Joel Zinberg, M.D., senior fellow at the Competitive Enterprise Institute and director of the Public…
The Wall Street Journal
The FTC Goes Evidence-Free
Through three years of Lina Khan’s leadership, the Federal Trade Commission has suffered an unprecedented streak of high-profile court defeats. That’s because the agency regularly makes…
News Release
New FTC study on drug costs fails to conduct empirical analysis of market conditions
The Federal Trade Commission (FTC) release a new study today claiming Pharmacy Benefit Managers (PBMs) are responsible for higher drug costs. FTC Commissioner Melissa Holyoak…
Blog
New FDA lab tests rule could bankrupt small labs
Yesterday the Food and Drug Administration (FDA) announced that on May 6 it will promulgate a rule under its authority to regulate medical devices.
City Journal
A Solution in Search of a Problem
In his State of the Union address, President Biden touted the drug-price controls in his Inflation Reduction Act (IRA). Though the price controls have yet…
City Journal
Ignoring the Science
A new CDC study reports that the first updated Covid-19 vaccine—the bivalent vaccine approved in fall 2022—was about 50 percent effective in blocking infection over a two-month…
The Federalist Society
Explainer 62 – FDA’s Regulation of Laboratory Developed Tests
CEI’s Joel Zinberg joined a podcast hosted by The Federalist Society for the Regulatory Transparency Project on the FDA’s regulation of laboratory developed tests:…
National Review
When Science Is Not Science
Just 22 percent of all adults and 41 percent of those 65 and older — the most vulnerable group — have received the updated 2023–24 Covid-19 vaccine.
Washington Times
Cutting-edge drugs could vanish under Biden’s unprecedented move to seize patents
CEI’s Dr. Joel Zinberg is cited in the Washington Times on the Biden Administration’s move to seize patents: Dr. Joel Zinberg, a senior fellow…
National Review
Another FDA Power Grab
The comment period for the Food and Drug Administration’s latest power grab has just concluded. Roughly 20,000 comments were submitted addressing the FDA’s proposed rule which…
News Release
CEI leads coalition calling on Congress to repeal drug price control provisions of the Inflation Reduction Act
The Competitive Enterprise Institute (CEI) and a coalition 43 conservative and free market groups sent a letter to Congress today calling for the…
Letters
Coalition Letter to End IRA Prescription Drug Price Controls
October 31, 2023 Dear Members of Congress, When the Inflation Reduction Act was passed and signed into law a year ago, the legislation granted the…
National Review
Restricting Pharmacy Benefit Managers Could Decrease Competition and Increase Drug Costs
Congress is considering multiple bills that aim to restrict the ability of pharmacy benefit managers (PBMs) to negotiate discounts and rebates and to require the PBMs…
Wall Street Journal
Court to FDA: Stop Playing Doctor
The Food and Drug Administration regulates pharmaceuticals, but it has no business playing doctor and giving you medical advice. That’s the message of a Sept.
Washington Examiner
The Biden administration shouldn’t waste more taxpayer dollars on COVID vaccines
A Food and Drug Administration advisory committee recently voted to recommend updating the COVID-19 vaccine. But important questions remain: When…
The Center Square
Fauci takes heat after casting doubt on efficacy of COVID vaccines
CEI’s Joel Zinberg is cited in The Center Square on COVID vaccines: Joel Zinberg, a Competitive Enterprise Institute senior fellow, blasted Fauci for pushing for…
Blog
New Inflation Numbers Show Folly of Price Controls
Today’s release of inflation numbers by the Bureau of Labor Statistics confirms that the loudest voices in favor of price controls are usually the…
Letters
CEI Joins Coalition Opposing March-In over Drug Prices
Dear Secretary Becerra, On behalf of millions of Americans across the country, we urge you to ignore calls and petitions asking you to deliberately twist…
Letters
CEI Joins Coalition Urging Congress to End Ban on DC Marijuana Sales
Dear Members of Congress, As you and your colleagues in Congress continue to finalize funding levels and bill language in the FY22 appropriations bill, the…
Letters
CEI Joins NTU-Led Coalition Warns of BBB’s Impact on Drug Competition
Dear Senators and Representatives: On behalf of the undersigned organizations — taxpayer, consumer, and free market advocates from across the country — we write with…
Letters
CEI Joins ATR Led Drug Price Control Coalition Letter
Dear Member of Congress: We write in opposition to the Democrat plan to impose price controls, a 95 percent excise tax, and inflation penalties on…
National Review
Innovators to the Rescue
Thirty years ago, I spoke at a conference on xenotransplantation — the transplantation of organs, cells, or tissues between species — at Columbia…
Blog
Democrats’ Drug Price Control Bill Is a Prescription for Disaster
Last Thursday, House Democrats reintroduced a bill from the last Congress, which they claim will protect Medicare from excessive prescription drug prices. Sadly, it…
Blog
More Good News on the Road to Ending the Pandemic
A new study from the Center for Disease Control and Prevention, which shows that a single dose of either the Pfizer-BioNTech or the Moderna…
Blog
Prescription Drug Price Controls are a Trump Legacy Worth Eradicating
During his first month in office, President Biden has seemingly been more interested in eradicating Donald Trump’s legacy than pushing his own proposals, though…
Blog
Employers Will Pay Workers to Get a Covid-19 Vaccine
The federal government, through Operation Warp speed, helped develop and bring to market vaccines against the new disease COVID-19 in less than a year, an…
Blog
COVID-19 Vaccine Development Is Testament to the Market’s Ability to Develop Life-Saving New Products
The announcement by drug maker Moderna that preliminary data from its still ongoing trial shows its COVID-19 vaccine is 95 percent effective is extremely encouraging.
Blog
New CEI Report: Making Sure a COVID-19 Vaccine Is Used
One or more COVID-19 vaccines will likely be approved in the next few months. But this scientific achievement may prove to be the easy part.
City Journal
Following The Science — Where?
When doctors meet a patient for a new complaint, we make a list of different possible explanations for the problem—a differential diagnosis—and try to determine…
News Release
CEI Welcomes Senior Fellow with Health Care and Legal Expertise
The Competitive Enterprise Institute is pleased to welcome medical and legal expert Joel M. Zinberg, M.D., J.D. as a senior fellow working on health care…
Blog
How SEC Accounting Regulations Hindered National Stockpile—and Still May Be Doing So
In a new report, CEI experts outline #NeverNeeded regulations that are frustrating responses to the pandemic and its aftermath. Among those is an obscure Securities…
Blog
Getting Rid of #NeverNeeded Regulations Hindering Coronavirus Response
What can Washington do to minimize harm from the coronavirus? Some of the best policy responses are coming not from imposing new regulations, but from…
Blog
Liberty in the Time of Coronavirus Part 2
Much of the money dedicated to medical research and services comes from the federal government. While some may see this is a good way to…
Blog
Regulation, Confusion, and the Irony of Emergency COVID-19 Testing
By now, readers are aware that testing in the United States for the novel coronavirus COVID-19 has been embarrassingly slow. Less well known is that…
Blog
Trump Administration Expected to Adopt Socialized Medicine Drug Pricing Control Scheme
Regardless of the outcome of the Iowa Caucuses on Monday night, the successive presidential campaigns of Democratic Socialist Senator Bernie Sanders (I-VT) have dragged the…
Fox News
Pelosi, Progressive Caucus Clash over Drug Pricing Legislation
Fox News cites Research Fellow Patrick Hedger on Nancy Pelosi’s proposed “Lower Drug Costs Now Act.” But according to the right-leaning Competitive Enterprise…
News Release
House Bill Setting Price Controls on Medicines Would Endanger Patients, Harm Innovation
House Speaker Nancy Pelosi and Majority Leader Steny Hoyer plan to bring H.R. 3, the Lower Drug Costs Now Act, to the floor for a…
Real Clear Markets
With Drug Pricing, Bipartisanship Isn’t an Excuse to Violate the Laws of Economics
In an age of intense political polarization, some may assume anything that House Speaker Nancy Pelosi and President Donald Trump even marginally agree on has…
The Economic Standard
Drug Reference Pricing Threatens Patient Health, Innovation
The Economic Standard cites Research Fellow Patrick Hedger and CEI’s event on drug reference pricing: Some recent proposals to lower drug prices are…
News Release
Foreign Reference Pricing Schemes Threaten Patient Health and America’s Leadership in Medical Innovation
International policy experts and patients gathered today in Washington, D.C. to discuss the potential impact of foreign reference pricing schemes, which have been proposed by the…
News Release
International Experts Voice Concerns About International Pricing Index and Foreign Reference Pricing Proposals for Prescription Drugs
To address the cost of prescription medicines, the Trump administration and congressional leaders have proposed instituting international reference pricing policies, like the International Pricing Index…
Letters
CEI Joins Coalition Letter Opposing Pelosi Drug Tax Plan
Dear Members of Congress: We write in opposition to the prescription drug pricing bill offered by House Speaker Nancy Pelosi that would impose an excise…
Blog
Bogus E-cigarette Panic Literally Killing People
Is this a story from The Onion? It’s a question we often ask ourselves these days when we encounter stories online that seem too ridiculous…
Letters
CEI Joins Coalition Letter to Urge President Trump to Halt Regulatory Assault on Innovative Electronic Cigarette Industry
We urge you to immediately halt the Food and Drug Administration’s aggressive regulatory assault on businesses who sell and consumers who rely on less harmful…
Marijuana Moment
Congress Clashes On Marijuana Amendments In Floor Debate
Marijuana Moment cites Senior Fellow Michelle Minton’s recent work on marijuana policy. Meanwhile, the amendment enjoys support from a coalition of fiscally conservative thought…
Marijuana Moment
Federal Government Violated the Law in Marijuana Scheduling Evaluation, Group Says
Marijuana Moment cites Senior Fellow Michelle Minton’s request for correction on the Department of Health and Human Services’ medical marijuana evaluation. The Competitive…
Blog
Department of Health and Human Services Needs to Correct Record on Marijuana
Regulators at the federal Drug Enforcement Agency (DEA) had an opportunity in 2016 to move marijuana into a less restrictive category of controlled substances. This…